Global Fabry Disease Market 2015-2019

01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05. Disease Overview
05.1 Lysosomal Storage Disorders
05.2 Fabry Disease
05.2.1 Etiology and Pathophysiology
05.2.2 Signs and Symptoms
05.2.3 Epidemiology
05.2.4 Inheritance Pattern
06. Introduction
07. Market Landscape
07.1 Market Overview
07.2 Market Size and Forecast
07.3 Historical Analysis of Global Fabry Disease market
07.4 Five Forces Analysis
08. Market Segmentation by Cell Line Used for Manufacturing the Drug
09. Geographical Segmentation
10. Buying Criteria
11. Market Growth Drivers
12. Drivers and their Impact
13. Market Challenges
14. Impact of Drivers and Challenges
15. Market Trends
16. Trends and their Impact
17. Vendor Landscape
17.1 Competitive Scenario
17.1.1 Key News
17.1.2 Mergers and Acquisitions
17.2 Market Share Analysis 2014
17.3 Other Prominent Vendors and Future Vendors
18. Pipeline Analysis
18.1 Clinical Trial Analysis of Pipeline Candidates
18.1.1 AT1001
18.1.2 GZ402671
18.1.3 PRX-102
19. Fabry Registry
20. Key Vendor Analysis
20.1 Genzyme
20.1.1 Key Facts
20.1.2 Business Overview
20.1.3 Product Segmentation by Revenue 2013
20.1.4 Product Segmentation by Revenue 2012 and 2013
20.1.5 Geographical Segmentation
20.1.6 Business Strategy
20.1.7 Recent Developments
20.1.8 SWOT Analysis
20.2 Shire
20.2.1 Key Facts
20.2.2 Business Overview
20.2.3 Geographical Segmentation by Revenue 2013
20.2.4 Business Strategy
20.2.5 Recent Developments
20.2.6 SWOT Analysis
21. Other Reports in this Series